• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4644563)   Today's Articles (9504)   Subscriber (50663)
For: Zhang Y, Zhang XD, Wang Y. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study. Transplant Proc 2011;43:3697-701. [PMID: 22172829 DOI: 10.1016/j.transproceed.2011.08.105] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2011] [Revised: 07/23/2011] [Accepted: 08/31/2011] [Indexed: 11/22/2022]
Number Cited by Other Article(s)
1
Herrero‐Moyano M, Pedraz J, Muñoz‐Aceituno E, Chicharro P, Reolid A, Lara S, Daudén E. Trough (C0) and 2‐hour postdose (C2) cyclosporine monitoring in patients with moderate‐to‐severe psoriasis. J Eur Acad Dermatol Venereol 2019;33:e215-e217. [DOI: 10.1111/jdv.15481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
2
Filler G. No association between cyclosporine levels and dyslipidemia? Nephrourol Mon 2014;6:e14296. [PMID: 24719816 PMCID: PMC3968964 DOI: 10.5812/numonthly.14296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2013] [Accepted: 12/01/2013] [Indexed: 11/28/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA